US58510H1032 - ADR
TOKYO, Oct. 15, 2024 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (NASDAQ: MRM) announces that its subsidiary MEDIROM MOTHER Labs Inc. has...
TOKYO, Oct. 07, 2024 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (NASDAQ: MRM) (“Medirom” or the “Company”) is pleased to announce that it...
NFES Group Selected as Lead Investor in Series A Round Valued at 9 Billion Yen
NFES Group Selected as Lead Investor in Series A Round Valued at 9 Billion Yen...
TOKYO, July 22, 2024 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (“we”, “our”, “us” or “the Company”) hereby announces that its subsidiary...
NEW YORK, July 10, 2024 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (“we”, “our”, “us” or “the Company”) hereby announces that the Company...
Four Nasdaq-listed Japanese Companies Gather to Showcase the Appeal of Japanese Companies to the World
Four Nasdaq-listed Japanese Companies Gather to Showcase the Appeal of Japanese Companies to the World...
TOKYO, June 25, 2024 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (NASDAQ: MRM) (“Medirom” or the “Company”), a holistic healthcare company...
Discover the appeal of Japanese companies listed in the U.S.
“NASDAQ JAPAN IR EVENT” to Be Held at Nasdaq MarketSite on June 20, 2024 Discover the appeal of Japanese companies listed in the U.S....
Total Customers Served: 77,854 – Sales Per Customer: JPY 7,190 – Customer Repeat Ratio: 77.9%
MEDIROM Healthcare Technologies Inc. Announces March 2024 Key Performance Indicators (KPIs) ...
Announcement Execution of Memorandum of Understanding for Share Acquisition (Subsidiarization)...